|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||
Clinical |
The French REIN Registry,1 National Coordinating Centre, and Medical and Scientific Department,2 Biomedicine Agency, Saint-Denis La Plaine; Nephrology Department,3 Nancy University Hospital, Vandoeuvre les Nancy; Nephrology Unit,4 Clemenceau Hospital, Caen; and The French-Speaking Peritoneal Dialysis Registry,5 René Dubos Hospital, Cergy Pontoise, France
Correspondence to: C. Couchoud, The French REIN Registry, National Coordinating Center, Biomedicine Agency, 1 Avenue du Stade de France, 93212 Saint Denis la Plaine Cedex, France. cecile.couchoud{at}biomedecine.fr
In France, the use of peritoneal dialysis (PD) as the first-choice
treatment varies greatly between districts, as it is already known to do
between countries. Baseline clinical factors associated with choice of first
modality were analyzed in 10 815 new end-stage renal disease patients in 59
districts. To describe practices at the district level, we used an
agglomerative hierarchical classification, with proximity defined by a
likelihood-ratio test that compared multivariate logistic regressions of the
following factors: age, gender, diabetes, congestive heart failure, severe
behavioral disorders, mobility, and employment. To propose a typology, each
cluster of districts was described by a multivariate logistic regression.
While populations starting PD in France, as elsewhere, are more likely to be
young or employed, they are also more likely to be elderly or have congestive
heart failure or severe behavioral disorders. Overall, 14% of patients start
with PD, but this rate varies significantly across districts, from 0% to 45%.
A specific combination of factors was associated with the first-choice
modality in each group of districts. This study highlights the lack of
consensual medical criteria for this choice and the likelihood that nonmedical
factors may explain the observed differences. The high variability suggests
that PD can be used in almost all clinical conditions. Accordingly, patient
preference should play a more important role in the decision-making
process.
KEY WORDS: Epidemiology; first-choice treatment; variability; district; comorbidities; age; agglomerative hierarchical classification.
Received 22 November 2007; accepted 20 February 2008.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |